HC Surgical offers 30m new shares in Catalist IPO; public float fully taken up
Add BT as a preferred sourceSingapore
HC Surgical Specialists Ltd (HCSS), a medical services group focusing on endoscopic procedures, has offered 30 million new shares at S$0.27 apiece in its initial public offering on the Catalist board of Singapore Exchange (SGX).
The market capitalisation is expected to be about S$39.5 million. The public float of about 20 per cent is fully subscribed, it said.
TRENDING NOW
Singtel Q1 gain drops 71% to S$818 million in absence of Airtel stake sale; weaker Singapore business
Sembcorp raises interim dividend despite 72% H1 profit slide to S$150 million on Alinta deal costs
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
CDL H1 profit jumps three times to S$301 million on strong condo sales, doubles interim dividend
